Alto Neuroscience (ANRO) Depreciation & Amortization (CF) (2023 - 2026)
Alto Neuroscience has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $184000.0 for Q1 2026.
- Quarterly results put Depreciation & Amortization (CF) at $184000.0 for Q1 2026, down 8.0% from a year ago — trailing twelve months through Mar 2026 was $680000.0 (down 2.86% YoY), and the annual figure for FY2025 was $700000.0, up 40.0%.
- Depreciation & Amortization (CF) reached $184000.0 in Q1 2026 per ANRO's latest filing, down from $196000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $200000.0 in Q3 2024 and bottomed at $86000.0 in Q1 2023.
- Median Depreciation & Amortization (CF) over the past 4 years was $100000.0 (2023), compared with a mean of $143307.7.
- The largest annual shift saw Depreciation & Amortization (CF) soared 106.19% in 2025 before it decreased 8.0% in 2026.
- Over 4 years, Depreciation & Amortization (CF) stood at $100000.0 in 2023, then soared by 100.0% to $200000.0 in 2024, then dropped by 2.0% to $196000.0 in 2025, then dropped by 6.12% to $184000.0 in 2026.
- Business Quant data shows Depreciation & Amortization (CF) for ANRO at $184000.0 in Q1 2026, $196000.0 in Q4 2025, and $200000.0 in Q3 2025.